Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Provides SOLiD Systems to UK-Based Sequencing Hub for Translational Research Collaboration

Premium

By Julia Karow

Life Technologies said this week that through a collaboration with a sequencing center in Cambridge, UK, it is making its SOLiD platform available to scientists for translational research studies.

Under the collaboration, scientists at the Eastern Sequence and Informatics Hub at Addenbrooke's Hospital in Cambridge will use three SOLiD 3 Plus systems for targeted medical resequencing and whole-transcriptome studies in disease areas such as cancer, diabetes, and neurological disorders.

According to John Todd, a professor at the University of Cambridge and the leader of the sequencing center, "the translation of this information into clinically relevant knowledge will have a direct impact on the treatment of human disease through the development of better diagnostic, prognostic, and therapeutic agents."

The center was established earlier this year with £2.4 million ($4 million) from the UK's Medical Research Council, as well as funding from the University's Clinical School and NIHR Biomedical Research Centre.

Todd told In Sequence in May that the center, which has ongoing collaborations with both Life Technologies and Roche/454 Life Sciences, planned to acquire at least two types of second-generation sequencing systems (see In Sequence 5/19/2009).

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.